Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 197 Records) |
| Query Trace: Disease and Erbb2[original query] |
|---|
| Genetic insights into thymic carcinomas and thymic neuroendocrine neoplasms denote prognosis signatures and pathways. Chinese medical journal 2023 9 . Shuyuan Wang, Zhitao Gu, Lei Zhu, Yuchen Han, Hong Yu, Wentao Fang, Baohui H |
| Prognostic significance of TP53 and PIK3CA mutations analyzed by next-generation sequencing in breast cancer. Medicine 2023 9 102 (38): e35267. Jin Hyuk Choi, Jesang Yu, Minjung Jung, Junyong Jekal, Ku Sang Kim, Sung Ui Ju |
| Monitoring the Outcomes of Systemic Chemotherapy Including Immune Checkpoint Inhibitor for HER2-Positive Metastatic Gastric Cancer by Liquid Biopsy. Yonsei medical journal 2023 8 64 (9): 531-540. Seung-Hyun Jung, Choong-Kun Lee, Woo Sun Kwon, Sujin Yun, Minkyu Jung, Hyo Song Kim, Hyun Cheol Chung, Yeun-Jun Chung, Sun Young R |
| Clinicopathological and molecular analyses of uterine carcinosarcomas using next-generation sequencing: A single-center experience. Indian journal of pathology & microbiology 2023 8 66 (3): 449-455. Ezgi Genc Erdogan, Tülin D Yalta, Nuray Can, Necdet Süt, Ebru Ta?tekin, Ufuk Usta, Fulya Öz Puyan, Fatma E Ustural? Keskin, Busem B Ku |
| Genomic landscape of clinically advanced KRAS wild-type pancreatic ductal adenocarcinoma. Frontiers in oncology 2023 7 13 1169586. Prashanth Ashok Kumar, Serenella Serinelli, Daniel J Zaccarini, Richard Huang, Natalie Danziger, Tyler Janovitz, Alina Basnet, Abirami Sivapiragasam, Stephen Graziano, Jeffrey S Ro |
| Gene mutation profiling and clinical significances in patients with renal cell carcinoma. Clinics (Sao Paulo, Brazil) 2023 7 78 100259. Yongquan Wang, Peng He, Xiaozhou Zhou, Cong Wang, Jian Fu, Dawei Zhang, Deyang Liao, Zhansong Zhou, Chunman Wu, Wei Go |
| Unique Genomic Alterations and Microbial Profiles Identified in Gastric Cancer Patients of African, European, and Asian Ancestry: A Novel Path for Precision Oncology. Annals of surgery 2023 7 . Miseker Abate, Henry Walch, Kanika Arora, Chad M Vanderbilt, Teng Fei, Harrison Drebin, Shoji Shimada, Anna Maio, Yelena Kemel, Zsofia K Stadler, Joseph Schmeltz, Smita Sihag, Geoffrey Y Ku, Ping Gu, Laura Tang, Santosha Vardhana, Michael F Berger, Murray F Brennan, Nikolaus D Schultz, Vivian E Stro |
| The ERBB2 Exonic Variant Pro1170Ala Modulates Mitogen-Activated Protein Kinase Signaling Cascades and Associates with Allergic Asthma. International archives of allergy and immunology 2023 6 1-12. Yang Yie Sio, Wei Liang Gan, Wing Shan Ng, Sri Anusha Matta, Yee-How Say, Keng Foo Teh, Yi Ru Wong, Smyrna Moti Rawanan Shah, Kavita Reginald, Fook Tim Ch |
| Pertuzumab Plus Trastuzumab in Patients With Lung Cancer With ERBB2 Mutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO precision oncology 2023 6 7 e2300041. Apar K Ganti, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Elie G Dib, Herbert L Duvivier, Eugene R Ahn, Deepti Behl, Hossein Borghaei, Ani S Balmanoukian, Anu Gaba, Rui Li, Kwabena Osei-Boateng, Ramya Thota, Gina N Grantham, Abigail Gregory, Susan Halabi, Richard L Schils |
| ARID1A Mutation from Targeted NGS Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract Cancer. Cancer research and treatment 2023 5 . Sung Hwan Lee, Jaekyung Cheon, Seoyoung Lee, Beodeul Kang, Chan Kim, Hyo Sup Shim, Young Nyun Park, Sanghoon Jung, Sung Hoon Choi, Hye Jin Choi, Choong-Kun Lee, Hong Jae Ch |
| Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial. JAMA oncology 2023 5 . Stefania Napolitano, Vincenzo De Falco, Giulia Martini, Davide Ciardiello, Erika Martinelli, Carminia Maria Della Corte, Lucia Esposito, Vincenzo Famiglietti, Alessandra Di Liello, Antonio Avallone, Claudia Cardone, Alfonso De Stefano, Vincenzo Montesarchio, Maria Giulia Zampino, Roberto Bordonaro, Mario Scartozzi, Daniele Santini, Massimo Di Maio, Ferdinando De Vita, Lucia Altucci, Francesca Marrone, Fortunato Ciardiello, Teresa Troia |
| Pertuzumab Plus Trastuzumab in Patients With Endometrial Cancer With ERBB2/3 Amplification, Overexpression, or Mutation: Results From the TAPUR Study. JCO precision oncology 2023 4 7 e2200609. Ahn Eugene R, Rothe Michael, Mangat Pam K, Garrett-Mayer Elizabeth, Ali-Ahmad Hussein M, Chan John, Maitland Michael L, Patel Sapna R, Reese Zachary, Balmanoukian Ani S, Drescher Charles W, Li Rui, Tsimberidou Apostolia M, Leath Charles A, O'Lone Raegan, Grantham Gina N, Halabi Susan, Schilsky Richard |
| Genomic landscape and survival analysis of ctDNA "neo-RAS wild-type" patients with originally RAS mutant metastatic colorectal cancer. Frontiers in oncology 2023 4 13 1160673. Nicolazzo Chiara, Magri Valentina, Marino Luca, Belardinilli Francesca, Di Nicolantonio Federica, De Renzi Gianluigi, Caponnetto Salvatore, De Meo Michela, Giannini Giuseppe, Santini Daniele, Cortesi Enrico, Gazzaniga Pao |
| Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implications. Cancer medicine 2023 3 . Zhao Zhiming, Li Xiaomo, Wang Fei, Xu Yong, Liu Si, Han Quanli, Yang Zhiying, Huang Weiwei, Yin Zhuzeng, Liu Qu, Tan Haidong, Ma Tonghui, Si Shuang, Huang Jia, Yuan Hongling, Li Wei, Liu Ro |
| Racial Disparities in Pathological Complete Response Among Patients Receiving Neoadjuvant Chemotherapy for Early-Stage Breast Cancer. JAMA network open 2023 3 6 (3): e233329. Zhao Fangyuan, Miyashita Minoru, Hattori Masaya, Yoshimatsu Toshio, Howard Frederick, Kaneva Kristiyana, Jones Ryan, Bell Joshua S K, Fleming Gini F, Jaskowiak Nora, Nanda Rita, Zheng Yonglan, Huo Dezheng, Olopade Olufunmilayo |
| Poziotinib in Treatment-Naïve Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Mutations: ZENITH20-4, A Multicenter, Multicohort, Open-label Phase 2 Trial (Cohort 4). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2023 3 . Cornelissen Robin, Prelaj Arsela, Sun Sophie, Baik Christina, Wollner Mirjana, Haura Eric B, Mamdani Hirva, Riess Jonathan W, Cappuzzo Federico, Garassino Marina C, Heymach John V, Socinski Mark A, Leu Szu-Yun, Bhat Gajanan, Lebel Francois, Le Xiuning, |
| HLA-B*57:01/Carbamazepine-10,11-Epoxide Association Triggers Upregulation of the NF?B and JAK/STAT Pathways. Cells 2023 3 12 (5): . Haukamp Funmilola Josephine, Hartmann Zoe Maria, Pich Andreas, Kuhn Joachim, Blasczyk Rainer, Stieglitz Florian, Bade-Döding Christi |
| Molecular Landscape of Mullerian Clear Cell Carcinomas Identifies The Cancer Genome Atlas-like Prognostic Subgroups. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 3 36 (5): 100123. Irshaid Lina, Costigan Danielle C, Dong Fei, Matulonis Ursula A, Nucci Marisa R, Kolin David |
| Comprehensive molecular characterizations of stage I-III lung adenocarcinoma with tumor spread through air spaces. Frontiers in genetics 2023 2 14 1101443. Ye Ronghao, Yu Yongfeng, Zhao Ruiying, Han Yuchen, Lu Sh |
| Real-World Treatment Outcomes and Safety of Afatinib in Advanced Squamous Cell Lung Cancer Progressed after Platinum-Based Doublet Chemotherapy and Immunotherapy (SPACE Study). Cancers 2023 12 15 (23): . Wonjun Ji, In-Jae Oh, Cheol-Kyu Park, Sung Yong Lee, Juwhan Choi, Jae Cheol Lee, Jiwon Kim, Seung Hyeun L |
| Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in Taiwan. Breast cancer (Tokyo, Japan) 2023 12 . Bo-Fang Chen, Yi-Fang Tsai, Pei-Ju Lien, Yen-Shu Lin, Chin-Jung Feng, Yen-Jen Chen, Han-Fang Cheng, Chun-Yu Liu, Ta-Chung Chao, Jiun-I Lai, Ling-Ming Tseng, Chi-Cheng Hua |
| Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants. Breast cancer research and treatment 2023 12 . Christopher J Schwartz, Nikka Khorsandi, Amie Blanco, Rita A Mukhtar, Yunn-Yi Chen, Gregor Krin |
| Comparative Analysis of Mutational Patterns in Triple Negative Breast Cancer Before and after Neoadjuvant Chemotherapy in Patients with Residual Disease. Gene 2023 11 147980. Ashish Singh, Josh Thomas Georgy, Sakthi Dhananjayan, Elanthenral Sigamani, Ajoy Oommen John, Anjana Joel, Jagan Chandramohan, Rajadurai Abarna, Grace Rebekah, Selvamani Backianathan, Deepak Thomas Abraham, Mazhuvanchary Jacob Paul, Raju Titus Chacko, Marie Therese Manipadam, Rekha P |
| Endometrial carcinomas with ambiguous histology often harbor TP53 mutations. Virchows Archiv : an international journal of pathology 2024 9 . Ben Davidson, Karin Teien Lande, Daniel Nebdal, Anne Jorunn Nesbakken, Arild Holth, Kristina Lindemann, Ane Gerda Zahl Eriksson, Therese Sørl |
| Beyond tobacco: genomic disparities in lung cancer between smokers and never-smokers. BMC cancer 2024 8 24 (1): 951. Javiera Garrido, Yanara Bernal, Evelin González, Alejandro Blanco, Gonzalo Sepúlveda-Hermosilla, Matías Freire, Karen Oróstica, Solange Rivas, Katherine Marcelain, Gareth Owen, Carolina Ibañez, Alejandro Corvalan, Marcelo Garrido, Rodrigo Assar, Rodrigo Lizana, Javier Cáceres-Molina, Diego Ampuero, Liliana Ramos, Paola Pérez, Osvaldo Aren, Sara Chernilo, Cristina Fernández, María Loreto Spencer, Jacqueline Flores Aguila, Giuliano Bernal Dossetto, Mónica Ahumada Olea, Germán Rasse, Carolina Sánchez, Maria Galli de Amorim, Thais F Bartelli, Diana Noronha Nunes, Emmanuel Dias-Neto, Helano C Freitas, Ricardo Armis |
| PD-L1 expression in patients with non-small-cell lung cancer is associated with sex and genetic alterations: A retrospective study within the Caucasian population. Thoracic cancer 2024 6 . P Sarova, B Mosleh, S Zehetmayer, F Oberndorfer, J Widder, H Prosch, C Aigner, M Idzko, M A Hoda, D Gompelma |
| Clinicogenomic characterization of inflammatory breast cancer. bioRxiv : the preprint server for biology 2024 5 . Nolan Priedigkeit, Beth Harrison, Robert Shue, Melissa Hughes, Yvonne Li, Gregory J Kirkner, Liam F Spurr, Marie Claire Remolano, Sarah Strauss, Janet Files, Anne-Marie Feeney, Libby Grant, Ayesha Mohammed-Abreu, Ana Garrido-Castro, Romualdo Barroso Sousa, Brittany Bychkovsky, Faina Nakhlis, Jennifer R Bellon, Tari A King, Eric P Winer, Neal Lindeman, Bruce E Johnson, Lynette Sholl, Deborah Dillon, Beth Overmoyer, Sara M Tolaney, Andrew Cherniack, Nancy U Lin, Filipa Lyn |
| Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases. British journal of cancer 2024 5 . Thomas Aparicio, Julie Henriques, Magali Svrcek, Aziz Zaanan, Sylvain Manfredi, Andrea Casadei-Gardini, David Tougeron, Jean-Marc Gornet, Marine Jary, Eric Terrebonne, Guillaume Piessen, Pauline Afchain, Cédric Lecaille, Marc Pocard, Thierry Lecomte, Margherita Rimini, Frédéric Di Fiore, Valérie Le Brun Ly, Stefano Cascinu, Dewi Vernerey, Pierre Laurent Pu |
| A Novel AKT1, ERBB2, ESR1, KRAS, PIK3CA, and TP53 NGS Assay: A Non-Invasive Tool to Monitor Resistance Mechanisms to Hormonal Therapy and CDK4/6 Inhibitors. Biomedicines 2024 10 12 (10): . Alessandra Virga, Caterina Gianni, Michela Palleschi, Davide Angeli, Filippo Merloni, Roberta Maltoni, Paola Ulivi, Giovanni Martinelli, Ugo De Giorgi, Sara Bravacci |
| Clinicopathologic and genomic characteristics of biliary tract carcinomas with TERT promoter mutations among East Asian population. Pathology, research and practice 2025 1 266 155806. Inwoo Hwang, So Young Kang, Deok Geun Kim, Kee-Taek Jang, Kyoung-Mee K |
- Page last reviewed:Feb 1, 2024
- Content source: